Editorial discusses kidney-preserving strategies for upper tract urothelial carcinoma, highlighting recent advancements.
Hiroshi Hirata is an Editorial Board member of the International Journal of Urology. To minimize bias, he was excluded from all editorial decision-making related to the acceptance of this article for publication.
No takes yet. Share an insight, caveat, or question.
Helton Hiroshi Hirata (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: